Page last updated: 2024-08-18

arginine vasopressin and Precursor Cell Lymphoblastic Leukemia-Lymphoma

arginine vasopressin has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inui, D; Nishimura, M; Ohto, J1
Badenhoop, K; Bergmann, L; Haak, T; Raab, C; Schmidt, A; Usadel, KH; Weidmann, E1

Trials

1 trial(s) available for arginine vasopressin and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis.
    Clinical endocrinology, 1999, Volume: 50, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Endothelin-1; Endothelins; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Interleukin-2; Interleukin-6; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Pituitary-Adrenal System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Precursors; Stimulation, Chemical

1999

Other Studies

1 other study(ies) available for arginine vasopressin and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Massive melena due to arginine-vasopressin for septic shock in two pediatric patients.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:1

    Topics: Adolescent; Arginine Vasopressin; Child, Preschool; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Melena; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Shock, Septic; Vasoconstrictor Agents

2008